In last trading session, Rocket Pharmaceuticals Inc (NASDAQ:RCKT) saw 2.41 million shares changing hands with its beta currently measuring 0.89. Company’s recent per share price level of $6.05 trading at -$0.56 or -8.47% at ring of the bell on the day assigns it a market valuation of $652.36M. That closing price of RCKT’s stock is at a discount of -345.95% from its 52-week high price of $26.98 and is indicating a premium of 24.79% from its 52-week low price of $4.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.26 million shares which gives us an average trading volume of 2.67 million if we extend that period to 3-months.
For Rocket Pharmaceuticals Inc (RCKT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) trade information
Upright in the red during last session for losing -8.47%, in the last five days RCKT remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $6.05 price level, adding 18.13% to its value on the day. Rocket Pharmaceuticals Inc’s shares saw a change of -51.83% in year-to-date performance and have moved -9.63% in past 5-day. Rocket Pharmaceuticals Inc (NASDAQ:RCKT) showed a performance of 2.45% in past 30-days. Number of shares sold short was 12.26 million shares which calculate 3.03 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 32 to the stock, which implies a rise of 81.09% to its current value. Analysts have been projecting 32 as a low price target for the stock while placing it at a high target of 32. It follows that stock’s current price would drop -428.93% in reaching the projected high whereas dropping to the targeted low would mean a loss of -428.93% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.60% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 15.41% while estimates for its earnings growth in next 5 years are of 46.36%.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s Major holders
Insiders are in possession of 2.74% of company’s total shares while institution are holding 101.06 percent of that, with stock having share float percentage of 103.91%. Investors also watch the number of corporate investors in a company very closely, which is 101.06% institutions for Rocket Pharmaceuticals Inc that are currently holding shares of the company. RTW INVESTMENTS, LP is the top institutional holder at RCKT for having 17.69 million shares of worth $380.82 million. And as of 2024-06-30, it was holding 18.8677 of the company’s outstanding shares.
The second largest institutional holder is WELLINGTON MANAGEMENT GROUP LLP, which was holding about 9.16 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.7665 of outstanding shares, having a total worth of $197.12 million.
On the other hand, VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 7.6 shares of worth $46.0 million or 7.11% of the total outstanding shares. The later fund manager was in possession of 2.62 shares on Dec 31, 2024 , making its stake of worth around $15.87 million in the company or a holder of 2.46% of company’s stock.
